Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2005-06-08
2010-10-19
Sullivan, Daniel M (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
Reexamination Certificate
active
07816557
ABSTRACT:
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
REFERENCES:
patent: 5811459 (1998-09-01), Breault et al.
patent: 6489333 (2002-12-01), Pitts et al.
patent: 2003/0065031 (2003-04-01), Madsen et al.
patent: 2008/0125468 (2008-05-01), Chappell et al.
patent: 2008/0280982 (2008-11-01), Li et al.
patent: 2008/0300289 (2008-12-01), Chappell et al.
patent: 2008/0300308 (2008-12-01), Li et al.
patent: 2008/0319074 (2008-12-01), Chappell et al.
patent: 2009/0156655 (2009-06-01), Conner et al.
patent: 0288305 (1998-10-01), None
patent: WO 03/048109 (2003-06-01), None
patent: WO 2004/002480 (2004-01-01), None
patent: WO 2004/056763 (2004-07-01), None
patent: WO 2006/102067 (2006-09-01), None
U.S. Appl. No. 11/815,987, filed Feb. 9, 2006, Chappel, Mark et al.
Brown et al., Hydroxacetophenone-derived antagonists of the peptidoleukotrienes,Journal Med. Chem., 32(4), pp. 807-826, 1989.
Beasley, H. L. et al., Development of a Panel of Immunoassays for Monitory DDT, Its Metabolites, and Analogs in Food and Environmental Matrixes,Journal of Agricultural and Food Chemistry, 46(8), pp. 3339-3352; compound HAPTEN VI, 1998.
Kundu B et al., Identification of novel alpha-glucosidase inhibitors by screening libraries based on N-[4-(Benzyloxy) benzoyl] Alanine derivatives,Chemical Abstracts Service, 5(7), pp. 545-550, 2002.
Kurukulasuriya et al., “Biaryl amide glucagon receptor antagonists”Bioorganic&Medicinal Chemistry Letters, vol. 14, No. 9, pp. 2047-2050, 2004.
Conner Scott Eugene
Zhu Guoxin
Eli Lilly and Company
Sullivan Daniel M
Valenrod Yevegeny
Wood Dan L.
LandOfFree
Glucagon receptor antagonists, preparation and therapeutic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon receptor antagonists, preparation and therapeutic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonists, preparation and therapeutic uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152038